Image Source : FILE PHOTO/AP The suspension, which might be reviewed after two weeks, is anticipated to slowdown Denmark’s vaccination marketing campaign.
The well being authorities in Denmark mentioned on Thursday that they’re quickly suspending using AstraZeneca’s Covid-19 vaccine as a precautionary measure after some sufferers developed blood clots since receiving the jab, together with one who died, digital information writer The Local reported.
Apart from Denmark, Norway and Iceland have additionally quickly suspended using AstraZeneca’s Covid-19 vaccine.
The Danish resolution got here days after Austria suspended use of a specific batch of the drug as a result of a girl died 10 days after taking it. Estonia, Latvia, Lithuania and Luxemburg have additionally stopped utilizing the batch, the BBC reported.
ALSO READ: UK to obtain 10 million AstraZeneca COVID-19 vaccine doses from India
The transfer comes “following reports of serious cases of blood clots among people vaccinated with AstraZeneca’s Covid-19 vaccine”, the Danish Health Authority mentioned in an announcement.
But it cautiously added that “it has not been determined, at the time being, that there is a link between the vaccine and the blood clots”.
Nevertheless, it requested the regional authorities answerable for vaccine rollout to cease utilizing the AstraZeneca jab till additional discover, the report mentioned.
The report added that there’s “good evidence that the vaccine is both safe and effective”, however that it might seek the advice of with the Danish medicines company in two weeks on the matter.
“It is important to point out that we have not terminated the use of the AstraZeneca vaccine, we are just pausing its use,” Danish Health Authority Director Soren Brostrom mentioned within the assertion.
According to the well being authority, one individual had died after receiving the vaccine. The European Medicines Agency (EMA) in Denmark has launched an investigation into the loss of life.
“There is broad documentation proving that the vaccine is both safe and efficient. But both we and the Danish Medicines Agency must act on information about possible serious side-effects, both in Denmark and in other European countries,” Brostrom mentioned.
The suspension, which might be reviewed after two weeks, is anticipated to slowdown Denmark’s vaccination marketing campaign, the report mentioned
Latest World News
